Prosecution Insights
Last updated: October 04, 2026

Seer Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Computing & Software

6 pending office actions • 3 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Seer Inc. has 6 pending office actions within the Chemistry & Materials technology area. These actions are distributed among 5 distinct examiners and 3 distinct art units. This distribution suggests that while the portfolio is small, it still requires interaction with multiple examiners across a few different technical groups, necessitating a somewhat varied prosecution strategy.

The busiest examiner, FRITCHMAN, REBECCA M, is currently handling 2 pending office actions. This accounts for a significant portion of the 6 pending office actions, making this examiner a key figure in the company's current prosecution efforts. With 5 distinct examiners involved, the company must adapt to several different examination styles, even within the 3 distinct art units where the work is concentrated. The presence of 3 distinct art units indicates that the 6 pending office actions cover several different technical sub-specialties within the Chemistry & Materials field. Practitioners should monitor the 5 distinct examiners to ensure consistent arguments are made across the portfolio. The fact that 2 pending office actions are with a single examiner provides an opportunity for consolidated advocacy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (67%)
2
Medium (33%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (17%)
§103 only1 (17%)
Double-patenting + other1 (17%)
Multi-statute (no §101)3 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
50% of docket
1
Information Tech
17% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FRITCHMAN, REBECCA M 2 45.7% +35.3%
YAMASAKI, ROBERT J 1 67.6% +43.7%
COLENA, TRACY CHING-TIAN 1 80.0% +42.2%
HILL, GRACELYN MARKHAM 1 100.0% +0.0%
THOMPSON, MILANA KAYE 1 0.0% +0.0%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18395124 PARTICLE-BASED BIOSEPARATION ASSAYS COLENA, TRACY CHING-TIAN —
18318563 METHODS AND SYSTEMS FOR ANALYSIS OF MASS SPECTROMETRY DATA HILL, GRACELYN MARKHAM —
18164542 SYSTEMS AND METHODS FOR CREATING BIOMOLECULE EMBEDDINGS THOMPSON, MILANA KAYE —
18006142 PARTICLES AND METHODS OF ASSAYING FRITCHMAN, REBECCA M —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18763980 PARTICLES AND METHODS OF ASSAYING FRITCHMAN, REBECCA M 88d overdue
19378180 PEPTIDE DECORATED NANOPARTICLES FOR ENRICHMENT OF SPECIFIC PROTEIN SUBSETS YAMASAKI, ROBERT J —
18395124 PARTICLE-BASED BIOSEPARATION ASSAYS COLENA, TRACY CHING-TIAN —
18006142 PARTICLES AND METHODS OF ASSAYING FRITCHMAN, REBECCA M —

Top Art Units

Art UnitApps
1758 2
1657 1
2125 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19378180 PEPTIDE DECORATED NANOPARTICLES FOR ENRICHMENT OF SPECIFIC PROTEIN SUBSETS YAMASAKI, ROBERT J 1657 §103Other Non-Final OA — Pending Nov 03, 2025
18763980 PARTICLES AND METHODS OF ASSAYING FRITCHMAN, REBECCA M 1758 §103§112DP Final Rejection 88d overdue Pending Jul 03, 2024
18395124 PARTICLE-BASED BIOSEPARATION ASSAYS COLENA, TRACY CHING-TIAN — §102§103 Non-Final OA — Pending Dec 22, 2023
18318563 METHODS AND SYSTEMS FOR ANALYSIS OF MASS SPECTROMETRY DATA HILL, GRACELYN MARKHAM 2125 §101§102§103 Non-Final OA — Pending May 16, 2023
18164542 SYSTEMS AND METHODS FOR CREATING BIOMOLECULE EMBEDDINGS THOMPSON, MILANA KAYE — §103§112 Non-Final OA — Pending Feb 03, 2023
18006142 PARTICLES AND METHODS OF ASSAYING FRITCHMAN, REBECCA M 1758 §103§112Other Final Rejection — Pending Jan 19, 2023

Managing Seer Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month